Attached files
| file | filename |
|---|---|
| EX-99.1 - EX-99.1 - Assertio Therapeutics, Inc | a11-28983_1ex99d1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
Current Report
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 1, 2011
DEPOMED, INC.
(Exact name of registrant as specified in its charter)
001-13111
(Commission File Number)
|
California |
|
94-3229046 |
|
(State or other jurisdiction of |
|
(I.R.S. Employer Identification No.) |
|
incorporation) |
|
|
1360 O’Brien Drive, Menlo Park, California 94025
(Address of principal executive offices, with zip code)
(650) 462-5900
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 2.02 Results of Operations and Financial Condition
On November 1, 2011, Depomed, Inc. issued a press release announcing its financial results for the quarter ended September 30, 2011. The press release is attached hereto as Exhibit 99.1 and is incorporated by reference herein.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
On October 26, 2011, Tammy L. Cameron resigned as the Vice President, Finance of Depomed, Inc. (the “Company”). Ms. Cameron’s resignation will become effective December 31, 2011 or such earlier date as may be requested by the Company. Until her resignation becomes effective, Ms. Cameron will continue to serve as the Company’s Vice President, Finance, principal financial officer and principal accounting officer. Ms. Cameron intends to pursue another opportunity and her resignation is not related to any disagreement with the Company’s accounting, financial reporting or internal control over financial reporting.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
|
99.1 |
Depomed, Inc. Press Release issued on November 1, 2011 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
DEPOMED, INC. | |
|
|
|
| |
|
|
|
| |
|
Date: November 1, 2011 |
|
By: |
/s/ Matthew M. Gosling |
|
|
|
|
Matthew M. Gosling |
|
|
|
|
Senior Vice President and General Counsel |